
ALZpath inks global licensing deal with Abbott to push blood tests for Alzheimer’s
A global license could speed blood-based Alzheimer’s diagnostics, forcing competitors to rethink timelines, partnerships, and trial plans.
By Mohammed Al-Shehri·· 3 min
